Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sickle Cell Gene Therapy Makers Would Pay For Fertility Services In Medicaid Payment Model

19 Mar 2024

• By Cathy Kelly

• Source: Shutterstock

Related Content

Sickle Cell Gene Therapy In Medicaid: CMMI Model As ‘Bandwidth Extender’ For Less Resourced States

01 Feb 2024

Medicaid Payment Model For Sickle Cell Gene Therapy May Have Limited Impact Until 2026

27 Feb 2024

Related Companies

Vertex Pharmaceuticals Incorporated

Bluebird Bio

Additional Topics

United States Reimbursement Medicaid Gene Therapy Policy Blood & Coagulation Disorders BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.